Skip to main content


In End-use, the Biologics segment is expected to be the fastest-growing segment whereas pharmaceuticals are expected to be the largest growing segment. The demand for biologics by developed as well as developing countries is boosting the market growth. The success of biologics in treating cancer and other autoimmune diseases has enabled giant pharmaceuticals to invest in them.